NAGASAKI, Japan--(BUSINESS WIRE)--Cytori (NASDAQ: CYTX) announced that the first patient was enrolled in an investigator-initiated study using adipose-derived stem and regenerative cells to treat the chronic effects of radiation-induced local tissue injury. The 30-patient study is being conducted independently by Nagasaki University Hospital in Japan. Cytori’s Celution® 800 System is being used to process and extract patients’ own adipose tissue-derived stem and regenerative cells.
